ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,738.17
-0.13%
US Tech 100
19,436.00
-0.73%
다우존스 지수
42,313.00
0.33%
Bitcoin
65,786.45
-0.13%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cartesian Therapeutics Inc (RNAC)

  7. Cartesian Therapeutics Inc (RNAC) 뉴스

RNAC

Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RNAC
일자시간출처헤드라인심볼기업
2024/09/2620:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNACCartesian Therapeutics Inc
2024/09/0920:00GlobeNewswire Inc.Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile DermatomyositisNASDAQ:RNACCartesian Therapeutics Inc
2024/09/0620:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
2024/09/0320:00GlobeNewswire Inc.Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15NASDAQ:RNACCartesian Therapeutics Inc
2024/08/2620:00GlobeNewswire Inc.Cartesian Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RNACCartesian Therapeutics Inc
2024/08/0820:00GlobeNewswire Inc.Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
2024/08/0805:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2024/07/0905:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2024/07/0305:05GlobeNewswire Inc.Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal MalikNASDAQ:RNACCartesian Therapeutics Inc
2024/07/0219:31GlobeNewswire Inc.Cartesian Therapeutics Announces $130 Million Private Placement Equity FinancingNASDAQ:RNACCartesian Therapeutics Inc
2024/07/0219:31GlobeNewswire Inc.Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus ErythematosusNASDAQ:RNACCartesian Therapeutics Inc
2024/07/0219:30GlobeNewswire Inc.Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
2024/06/0620:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
2024/05/2220:00GlobeNewswire Inc.Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
2024/05/1405:30GlobeNewswire Inc.Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:RNACCartesian Therapeutics Inc
2024/05/0820:00GlobeNewswire Inc.Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
2024/05/0705:15Business WireCartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2024/04/2305:30Business WireCartesian Therapeutics to Present at the ASGCT 27th Annual MeetingNASDAQ:RNACCartesian Therapeutics Inc
2024/04/0420:30Business WireCartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:RNACCartesian Therapeutics Inc
2024/04/0420:00Business WireCartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2024/03/2905:05GlobeNewswire Inc.Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock SplitNASDAQ:RNACCartesian Therapeutics Inc
2024/03/0721:00GlobeNewswire Inc.Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
2024/03/0621:00GlobeNewswire Inc.Cartesian Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RNACCartesian Therapeutics Inc
2024/03/0521:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
2024/03/0521:00GlobeNewswire Inc.Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, MarylandNASDAQ:RNACCartesian Therapeutics Inc
2024/02/0606:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2024/01/0821:10GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for AutoimmunityNASDAQ:RNACCartesian Therapeutics Inc
2024/01/0821:00GlobeNewswire Inc.Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
2023/11/1322:05GlobeNewswire Inc.Selecta Biosciences Announces Merger with Cartesian TherapeuticsNASDAQ:RNACCartesian Therapeutics Inc
 검색 관련기사 보기:NASDAQ:RNAC

최근 히스토리

NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
COIN
AVAXUSD
Avalanche
CCOM
US30
US 30
FX
USDJPY
US Dollar vs Yen
NYSE
BAC
Bank of America
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
AMEX
XLV
Health Care Select Sector
NASDAQ
NVDA
NVIDIA
FX
USDGBP
US Dollar vs Sterling
COIN
DOGEUSD
Dogecoin
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유